AIM ImmunoTech Inc.
AIM
$0.12
-$0.0034-2.76%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -30.00% | 25.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -30.00% | 25.00% | |||
| Cost of Revenue | 0.00% | 0.00% | |||
| Gross Profit | -35.71% | 31.25% | |||
| SG&A Expenses | 18.83% | -33.84% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 20.83% | -35.16% | |||
| Operating Income | -21.52% | 35.58% | |||
| Income Before Tax | -101.53% | 68.44% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -101.53% | 68.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -101.53% | 68.44% | |||
| EBIT | -21.52% | 35.58% | |||
| EBITDA | -21.83% | 35.99% | |||
| EPS Basic | -85.01% | 70.49% | |||
| Normalized Basic EPS | -108.21% | 71.37% | |||
| EPS Diluted | -85.01% | 71.08% | |||
| Normalized Diluted EPS | -108.21% | 71.37% | |||
| Average Basic Shares Outstanding | 9.16% | 6.83% | |||
| Average Diluted Shares Outstanding | 9.16% | 6.83% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
